BUY TSM — Initiate 9% position in dominant foundry with elite fundamentals and technical momentum; hard stop at $394.44
▶WEEK 14Apr 20$107,152.13
SELL BMY x107 — TRIM_50 per sector rotation from Healthcare. Reduces defensive cluster concentration from 11.99% to 6.0%
SELL MRK x79 — TRIM_50 per sector rotation. Keytruda patent cliff risk (60% growth concentration, 2028 cliff). Reduces from 17.53% to 8.77%
SELL PM x10 — TRIM_25 to reduce Consumer Staples defensive exposure. Funds rotation to Materials/Cyclicals. Smoke-free transition execution risk
SELL T x35 — TRIM_25 to reduce Telecom defensive exposure. High debt load ($159.6B) constrains strategic flexibility
BUY PAAS — New position 10% allocation. Largest primary silver producer, strongest technical setup (golden cross, outperforming SPY). BUY_NOW signal. Use LIMIT near $58.17 to avoid chasing
▶WEEK 13Apr 13$109,267.37
HOLD — No trade opportunities met criteria this week.
▶WEEK 12Apr 6$102,209.21
SELL ENB x244.4087 — Circuit breaker - Energy sector avoided per macro guidance. Full position exit to raise cash.
SELL KMI x396.5333 — Circuit breaker - Energy sector avoided per macro guidance. Full position exit to raise cash.
SELL PFE x489.1732 — Risk override - Missing fundamental/risk data qualifies for exclusion. Drug pricing tariff threats and COVID trial halt create binary risks.
SELL PG x46 — Sector rotation - Consumer Staples avoided. Trim 50% from 12.9% to 6.44% weight. Bearish technical trend with low growth insufficient for 21x PE.
SELL PM x40 — Sector rotation - Consumer Staples avoided. Trim 50% from 12.64% to 6.33% weight. Heavy insider selling and FDA Zyn regulatory delays create uncertainty.
SELL SHEL x91.0312 — Sector rotation - Energy sector avoided per macro guidance. Full position exit; fairly valued with limited upside.
SELL SLB x166.4643 — Sector rotation - Energy sector avoided. Full position exit; high event risk with earnings April 24 and CEO insider selling concerning.
BUY GOOGL — New position at 18.75%. Dominant AI/search moat with exceptional valuation (PEG 0.89). 25% upside to targets. Entry timing: Wait for confirmation at $296 support.
BUY MRK — New position at 18.75%. Defensive compounder with perfect 4-quarter earnings beat history and golden cross. Keytruda franchise expansion supports premium valuation.
BUY MU — New position at 12.5%. HBM4 AI memory demand drives structural upgrade cycle with 756% earnings inflection. Golden cross technical structure with analyst upgrade momentum.
BUY BMY — New position at 12.5%. Value turnaround with golden cross and 6:1 risk/reward. Phase 3 trial success and Opdivo franchise support; $11B FCF validates sustainability.
▶WEEK 11Mar 30$103,403.66
SELL XOM x51.160156 — Full exit per cluster exposure cap - cyclical cluster limit 40% enforcement. Composite score 62.9 (C rating), extreme technical overbought conditions (RSI 77.9) at 52-week highs
SELL DVN x168.507261 — Full exit per cluster exposure cap - technical overbought (RSI 81.2) and 97% proximity to 52-week highs creates unfavorable risk/reward
SELL CTRA x228.342598 — Full exit per cluster exposure cap - trim high-performing energy position to meet cyclical cluster limit. Composite 63.8 (C rating) with technical overbought (RSI 80.9)
SELL CNQ x169.234182 — Full exit per cluster exposure cap - reduce Canadian energy exposure to comply with 40% cyclical limit. Composite 62.8 (C rating) with negative analyst asymmetry
SELL VZ x204.973648 — Full exit per sector rotation rule - Communication Services is macro avoided sector. Q4 margin compression and $185B debt overhang in rising rate environment
SELL T x143 — Reduce 50% per sector rotation rule - Communication Services sector avoided per macro guidance. Despite positive technicals, sector cap requires reduction to maintain reduced exposure for defensive yield
BUY USB — Minimal position increase to maintain target weight - Financials sector neutral per macro, strong insider buying signals support retention
BUY PM — New defensive position at target 13% - Best-in-class defensive asset in Consumer Staples cluster. Smoke-free transition (ZYN/IQOS) drives earnings growth with exceptional 67% margins and attractive 0.37x PEG valuation
BUY ENB — New defensive energy infrastructure position at target 13% - Premier infrastructure with defensive toll-road characteristics. Strong technical momentum (score 85) with golden cross, $26M Chairman insider buying demonstrates conviction
BUY PG — New defensive position at target 13% - Highest quality defensive moat Consumer Staples with 95 fundamental score. Unmatched brand portfolio provides pricing power in inflationary environment, low risk profile (32) with stable cash flows
BUY PFE — New defensive position at target 13% - Pharmaceutical value play with consistent earnings beat history. Attractive valuation at 11x P/E with 4.1% FCF yield, low risk profile suitable for defensive RISK-OFF regime positioning
BUY KMI — New energy infrastructure position at target 13% - Optimal defensive energy setup with 95 technical score and strong insider conviction ($26M Chairman purchase). Toll-road model benefits from natural gas/LNG demand, maintains cyclical cluster allocation within 40% limit
▶WEEK 10Mar 23$101,083.64
SELL GILD x49.652725012 — Healthcare sector in avoided list per macro guidance. Composite score 60.6 (Rating C). Technical consolidation with negative momentum. Rotate into favored Energy and Financials sectors.
SELL JNJ x29.606758927 — Healthcare sector in avoided list; score capped at 64 per macro rules. Despite strong fundamentals, defensive rotation out of healthcare into energy/infrastructure warranted per CIO mandate.
SELL KGC x681.829180327 — Composite score 62.7 below 65 threshold (Rating C). Gold miners under pressure with extreme IV (59%). Technical breakdown with death cross. Rotate capital into higher-conviction energy names.
SELL NEM x190.874621385 — Composite score 60.95 below 65 threshold. Extreme IV (60%) with inverted term structure signals acute stress. Technical breakdown below 50d MA. Sector rotation out of gold into oil-driven energy.
SELL VZ x204 — Position size exceeds 11.25% limit for LOW conviction (score 69.8). Trim to target weight to free capital for higher-ranked energy names while maintaining core holding.
BUY XOM — Integrated energy major with fortress balance sheet and strong FCF generation. Benefits from geopolitical oil premium and defensive characteristics in risk-off regime. Technicals show strong uptrend but extended above 200d MA.
BUY SHEL — Global integrated energy leader with excellent FCF generation ($22.7B) and conservative leverage. Benefits from LNG leadership and geopolitical supply disruptions. Strong technical uptrend with golden cross.
BUY SLB — Leading oilfield services provider with exceptional technical momentum and strong analyst upgrades. Benefits from international drilling recovery and subsea contract wins. Strong catalyst setup with 39 days to earnings and beat history.
BUY DVN — Premier E&P with strong Delaware Basin position and transformative Coterra merger catalyst. Conservative balance sheet and strong shareholder returns via variable dividend. Oil price leverage attractive in current geopolitical environment.
BUY CNQ — Canadian energy giant with exceptional profitability margins and strong insider alignment. Benefits from geopolitical hedge as Canadian operator. Strong earnings beat history and 45-day runway.
BUY USB — Regional banking leader with strong deposit franchise and improving net margins. Attractive valuation with PEG of 0.45 and 10% FCF yield. Interest rate sensitivity and CRE exposure are key risks.
BUY T — Telecom duopoly member with improving fundamentals and recent AI app catalyst. Strong free cash flow and deleveraging trajectory. High debt load remains concern.
▶WEEK 9Mar 16$105,188.62
SELL MRK x185.976320469 — Full exit per sector rotation rule - healthcare sector avoided, position 9x overweight vs 3% risk limit
SELL SLB x311.785946649 — Full exit per negative catalysts - rated C (59.1), Middle East disruption warning, $0.09 EPS hit exposure
SELL CTRA x228.342598475 — Trim 50% per profit-take instruction - technical overbought (RSI 74), reduce from 18.8% to 7%
SELL GILD x49.652725012 — Trim 50% per sector rotation - healthcare avoided but retain B-rated exposure given strong sentiment (90)
SELL JNJ x29.606758927 — Trim 50% per sector rotation - AAA balance sheet, lowest risk score (35) justifies partial retention
SELL B x279.879854886 — Materials sector in macro avoid list; score capped at 64. Underperforming position (-4.2%) in avoided cluster. Deploy proceeds to favored Energy or Healthcare.
SELL BMY x148.79589646 — Portfolio rebalancing - not in target allocation for risk-off defensive regime.
SELL GE x40.966993782 — Industrials (XLI) in macro avoid list with HIGH conviction avoidance; score capped at 64. High governance risk (9/10) and cyclical exposure inappropriate for risk-off regime.
SELL KGC x385.051515151 — Materials sector (gold mining) in avoid list; score capped at 64. Significant underperformance (-12.24%) and lack of competitive moat justify exit despite gold price tailwinds.
SELL KO x115.799627097 — Consumer Staples in macro avoid list (MEDIUM conviction). Score 61.85 below actionable threshold. Negative free cash flow in 2025 and premium valuation offer poor risk/reward.
SELL ZTS x72.709871176 — Score 51.8 below minimum threshold. CEO departure creates strategic uncertainty; technical death cross confirms deterioration. Limit loss on -5.81% underperformer.
BUY MRK — Merck offers the strongest risk-adjusted profile with consistent earnings beats (95 catalyst score), Keytruda franchise stability, and defensive healthcare positioning. Increasing position from 12.62% to 20.45%.
BUY GILD — Gilead demonstrates strong pipeline momentum with Anito-cel launch potential and HIV franchise stability. Superior sentiment (87) and catalyst scores (90) support entry despite valuation neutrality. New position at 13.64%.
BUY CTRA — Coterra Energy offers top-tier fundamentals (87) with low-cost Marcellus/Permian assets and conservative leverage (1.0x debt/OCF). Aligns with macro energy overweight guidance. New position at 13.64%.
BUY JNJ — Johnson & Johnson provides fortress balance sheet quality (88 fundamental) with defensive diversification across pharma and medtech. Recent FDA approvals (Tecvayli combo) support near-term catalysts. New position at 13.64%.
BUY SLB — Schlumberger benefits from Iran conflict-driven energy capex cycle with strong earnings consistency (3/4 beats). Goldman Sachs upgrade cycle and 53-day clean runway to earnings provide catalyst visibility. New position at 13.64%.
▶WEEK 7Mar 2$111,849.24
SELL MS x37.898068911 — Financial sector avoided per macro guidance; exit sector rotation candidate with -8.8% unrealized loss and negative $17.9B FCF
SELL VICI x629.193044712 — C-rated position with technical AVOID signal; capture +6.7% unrealized gain before catalyst deterioration
SELL B x84 — Trim position from 16.3% to target 12.5% for portfolio rebalancing; maintain core Materials exposure
SELL GE x11 — Trim position from 16.02% to target 12.5% for portfolio rebalancing; maintain Aerospace exposure
SELL ZTS x37 — Trim 25% of position per profit protection plan; reduce sector concentration while maintaining exposure to defensive animal health franchise
BUY KGC — New 12.5% position in gold miner with exceptional technical momentum (100 score); leveraged gold play benefiting from late-cycle defensive rotation and safe-haven demand; STOP at $36.36
BUY KO — New 8.33% position in defensive consumer staple; trading at 52-week highs with golden cross; appropriate for late-cycle capital preservation with 25% cash mandate
BUY BMY — Add to BMY to reach target 8.33% weight; maintaining trimmed position for healthcare exposure despite patent cliff risks
BUY MRK — Minor addition to reach exact 12.5% target; perfect earnings beat history, Keytruda franchise solid
▶WEEK 6Feb 23$109,267.37
HOLD — No trade opportunities met criteria this week.
▶WEEK 5Feb 17$109,303.95
SELL BMY x59 — Trim position from 8.38% to 5.1% per profit take rule
SELL COP x212.909988 — Full exit per cluster limit reduction - Energy cluster enforcement
SELL DVN x164.498957 — Full exit before binary earnings event - catalyst risk management
SELL GILD x61.478929 — Full exit per portfolio restructuring - 22% unrealized gains realized
SELL HAL x662.433859 — Full exit per cluster limit reduction - Energy cluster enforcement
SELL MS x24 — Trim position from 9.72% to 5.9% - reduce cyclical cluster exposure
SELL NEM x86.933158 — Full exit before T+2 earnings - catalyst score 25 triggers position closure
SELL PG x134.892734 — Full exit per defensive reallocation - technical consolidation risk
SELL SHEL x298.652393 — Full exit per cluster limit reduction - Energy cluster enforcement
SELL SLB x458.597934 — Full exit per cluster limit reduction - Energy cluster enforcement
SELL T x780.107989 — Full exit per sector rotation rule - Comm Services in avoided_sectors list
SELL VICI x104 — Trim position from 19.81% to 17% - reduce concentrated REIT exposure
BUY B — Initiate new position at 15.6% - defensive gold exposure with PEG 0.10 valuation support
BUY GE — Initiate new position at 15.6% - aerospace duopolist with United contract catalysts
BUY MRK — Initiate new position at 12.7% - KEYTRUDA franchise defensive pharma with technical support
BUY ZTS — Initiate new position at 12.7% - animal health leader with pet humanization tailwinds
▶WEEK 4Feb 9$108,639.25
SELL CMCSA x693.568 — SECTOR_ROTATION: Communication Services in macro avoided_sectors with HIGH conviction. Governance risk score 10/10 indicates severe control deficiencies. Full position exit per IC directive.
SELL DVN x54 — PROFIT_TAKE: Position up 14.5% with unfavorable risk/reward at 52-week highs (99%). RSI 77 indicates overbought conditions. Trim 25% while maintaining energy exposure.
BUY SHEL — New position at 21.25% target weight. Integrated energy supermajor with 12.3% FCF yield and golden cross technical momentum. Value Rotation regime primary beneficiary.
BUY COP — New position at 21.25% target weight. Pure-play E&P with $1B cost cut catalyst and breakout at 52-week highs. Requires stop loss at $105.96 given commodity exposure.
BUY SLB — New position at 21.25% target weight. Oilfield services leader with $1.5B Kuwait contract catalyst. Post-earnings clarity with strong analyst upgrade momentum.
BUY HAL — New position at 21.25% target weight. Oilfield services value play with 7.2% FCF yield and post-earnings upgrade momentum. Risk tier limits position size to 1% per directive - scaling applied.
BUY BMY — Micro-adjustment to maintain 8.57% target weight. HOLD status per IC: Rating C with stop loss at $55.55.
BUY GILD — Micro-adjustment to maintain 8.54% target weight. HOLD status per IC: Earnings tomorrow (Feb 10) creates binary event - do not add ahead of event.
BUY MS — Micro-adjustment to maintain 10.43% target weight. HOLD status per IC: Maintain for financial sector rotation and wealth management growth narrative.
BUY NEM — Micro-adjustment to maintain 9.56% target weight. HOLD status per IC: Gold momentum supportive with stop loss at $115.98 given commodity volatility.
BUY T — Micro-adjustment to maintain 19.37% target weight. HOLD status per IC: 18% upside to valuation target with stop loss at $26.24.
▶WEEK 3Feb 2$103,306.98
SELL MRK x103.337632213 — Circuit breaker: Immediate binary earnings event (Feb 3) with high IV (38.5%). Healthcare sector explicitly avoided in macro guidance. Score capped at 64 due to sector restriction. Preserve capital ahead of volatility.
SELL PYPL x195.807205623 — Stop loss triggered: Technical breakdown (score 0/100) with price below all MAs. Binary earnings event Feb 3 with extreme IV (77%). Fundamental concerns on margin compression and moat erosion. Score 45.2 (C rating).
SELL BMY x50 — Sector rotation trim: Healthcare sector avoided per macro guidance. Reducing position from 10.87% to 8.15% per orchestrator directive. Score capped at 64 from 66.8 due to sector restriction. Maintain reduced exposure given insider buying and pipeline optionality.
SELL DVN x72 — Risk reduction trim: Energy sector favored by macro, but composite score 57.9 (C rating) due to negative FCF and governance concerns. Reducing position from 11.34% to 8.52% while maintaining energy allocation. High risk score (78) warrants reduced exposure.
SELL GILD x20 — Sector rotation trim: Healthcare sector avoided. Composite score 57.4 (C rating). Despite strong technical trend, reducing exposure from 11.21% to 8.41% to avoid sector concentration. Patent cliff risks on HIV portfolio warrant caution.
BUY T — New position at 20% weight. Post-Lumen fiber acquisition clarity with strong Q4 wireless execution. Valuation discount to peers (9.1x P/E) and 8% FCF yield support margin of safety. Communication Services emerging as preferred defensive growth sector.
BUY PG — New position at 20% weight. Defensive quality anchor with 88 fundamental score and 60+ year dividend track record. Clean 80-day catalyst runway to April earnings with consistent beat history. Consumer Staples outperforming (+7.56% YTD) in defensive rotation.
BUY VICI — New position at 20% weight. Experiential REIT trading at 10.7x P/E vs sector 15-18x. Triple-net lease structure provides bond-like cash flow stability with CPI-linked escalators. Recent gaming portfolio diversification reduces concentration. 25% analyst upside aligns with 5.3% implied dividend yield.
BUY CMCSA — New position at 20% weight. Clean 81-day catalyst runway with consistent earnings beat streak. Broadband infrastructure moat with regional monopoly pricing power. Super Bowl campaign provides near-term sentiment lift. Communication Services weekly leader (+2.06%) with defensive growth characteristics.
▶WEEK 2Jan 26$103,993.83
SELL BMY x14 — Reducing position from 11.46% to 10.71% target weight